RGAGX
Price
$77.25
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
VILSX
Price
$40.26
Change
-$0.00 (-0.00%)
Updated
Sep 19 closing price
Ad is loading...

RGAGX vs VILSX

Header iconRGAGX vs VILSX Comparison
Open Charts RGAGX vs VILSXBanner chart's image
American Funds Growth Fund of Amer R6
Price$77.25
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Value Line Select Growth Institutional
Price$40.26
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
RGAGX vs VILSX Comparison Chart
Loading...
VS
RGAGX vs. VILSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAGX is a StrongBuy and VILSX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 284B vs. VILSX (450M). RGAGX pays higher dividends than VILSX: RGAGX (0.75) vs VILSX (0.00). RGAGX was incepted earlier than VILSX: RGAGX (15 years) vs VILSX (4 years). RGAGX is a more actively managed with annual turnover of: 31.00 vs. VILSX (14.00). RGAGX has a lower initial minimum investment than VILSX: RGAGX (250) vs VILSX (100000). RGAGX annual gain was more profitable for investors over the last year : 24.16 vs. VILSX (15.57).
RGAGXVILSXRGAGX / VILSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years4 years-
Gain YTD19.58614.903131%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets284B450M63,111%
Annual Yield % from dividends0.750.00-
Returns for 1 year24.1615.57155%
Returns for 3 years-2.53-8.4730%
Returns for 5 years52.01N/A-
Returns for 10 years64.63N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSG17.550.68
+4.03%
Inseego Corp
STRL134.944.59
+3.52%
Sterling Infrastructure
CMI300.65-0.94
-0.31%
Cummins
GENI7.65-0.26
-3.29%
Genius Sports Limited
EPIX6.05-0.72
-10.64%
ESSA Pharma